Palvella Therapeutics Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Palvella Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $229. The average 1-year stock price forecast is 109.71% higher than the current stock price, while the lowest is $205 (+87.73%) and the highest is $270 (+147.25%).

Price Target: $229 (+109.71%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$205	$229	$225	$270
Change	+87.73%	+109.71%	+106.04%	+147.25%

Analyst Ratings

The average analyst rating for Palvella Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	12	12	12	11	11	10
Buy	4	5	5	4	4	5
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	17	17	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sudan Loganathan Stephens & Co.	Stephens & Co.	Buy Initiates $220	Buy	Initiates	$220	+101.47%	May 12, 2026
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $210 → $240	Strong Buy	Maintains	$210 → $240	+119.78%	Mar 31, 2026
Andrew S. Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $255 → $270	Strong Buy	Maintains	$255 → $270	+147.25%	Mar 24, 2026
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $210	Strong Buy	Maintains	$210	+92.31%	Mar 16, 2026
Graig Suvannavejh Mizuho	Mizuho	Buy Maintains $205 → $250	Buy	Maintains	$205 → $250	+128.94%	Feb 25, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

29.05M

EPS This Year

-5.29

from -3.71

EPS Next Year

-6.13

from -5.29

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	-	-	-	-	-	29.05M	111.23M
Revenue Growth	-	-	-	-	-	-	282.88%
EPS	-4.82	2.17	-7.83	-3.71	-5.29	-6.13	-3.50
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	18	18	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	74.7M
Avg	n/a	29.1M
Low	n/a	10.8M

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-3.62	-1.62
Avg	-5.29	-6.13
Low	-6.64	-10.77

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.